Lucyd15 Jul 2020 14:48
So they value this innovative eyeware at just under $4 million and Lucyd have licensed the IP to them, do these jokers not realise that the shareholders should be told the details of any license agreement, the costs, numbers, royalties ECT. They really are quickly becoming one if the worst for communication. And as for the Belluscura user trial that was meant to happen in February, I personally believe it didn't take place, it was pulled and as such there's no RNS because there are no results.